Neurological Manifestations Associated With Hypomagnesemia Due to Proton-Pump Inhibitors: A Case Series
Abstract
We discuss a case series that explores the presentation and diagnostic challenges of three elderly male patients with hypomagnesemia. This series highlights the association between hypomagnesemia and hypocalcemia, both of which contribute to neurological symptoms. Proton-pump inhibitors, when taken for a long duration, are known to cause hypomagnesemia. This series also emphasizes the reversible neurological syndromes in patients with hypomagnesemia due to prolonged pantoprazole intake.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.